Please login to the form below

Not currently logged in
Email:
Password:

Daichii Sankyo

This page shows the latest Daichii Sankyo news and features for those working in and with pharma, biotech and healthcare.

Astellas, Daiichi Sankyo and Takeda to study biomarkers

Astellas, Daiichi Sankyo and Takeda to study biomarkers

Astellas, Daiichi Sankyo and Takeda to study biomarkers. Collaboration aims to establish comprehensive database to accelerate drug development. ... Japanese pharmaceutical firms Astellas, Daiichi Sankyo and Takeda have joined forces to create a

Latest news

  • AZ and Daiichi Sankyo sign Movantik marketing deal AZ and Daiichi Sankyo sign Movantik marketing deal

    AZ and Daiichi Sankyo sign Movantik marketing deal. Two firms have agreed the deal for the new constipation pill. ... AstraZeneca has announced a new co-commercialisation agreement with Daiichi Sankyo for the constipation drug Movantik (naloxegol) in the

  • Thin on the ground

    Daichii Sankyo is developing edoxaban tosylate, which is also an orally active direct factor Xa inhibitor.

  • News in brief, June 20, 2007

    Its clients include US and EU pharmaceutical and biotechnology corporations including Allergan, Biogen Idec, Bristol-Myers Squibb, sanofi-aventis and Daichii Sankyo.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics